Systems and methods for monitoring organ activity

US9492113B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9492113-B2
Application numberUS-201213535741-A
CountryUS
Kind codeB2
Filing dateJun 28, 2012
Priority dateJul 15, 2011
Publication dateNov 15, 2016
Grant dateNov 15, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A medical device for monitoring physical, chemical, or biological characteristics of an organ, such as the urinary bladder. The medical device may include an elongate member having a proximal end and a distal end. The device may further include an end-effector assembly extending distally from the distal end of the elongate member. The end-effector assembly may also include a plurality of sensing elements for detecting abnormal organ function. Each of the plurality of sensing elements may include one or more of mechanical, visual, chemical, and biological sensors.

First claim

Opening claim text (preview).

What is claimed is: 1. A medical device, comprising: an elongate member having a proximal end and a distal end; and an end-effector assembly extending distally from the distal end of the elongate member, the end-effector assembly including a plurality of independently steerable sensing elements for detecting abnormal organ function, wherein the plurality of sensing elements includes one or more of mechanical, chemical, and biological sensors; wherein the end-effector assembly further includes a plurality of longitudinally-extending legs and at least one circumferentially-extending leg which form a three-dimensional sphere, wherein each of the plurality of longitudinally-extending legs and the at least one circumferentially-extending leg defines a lumen therein, and at least a portion of at least one of the plurality of independently steerable sensing elements is disposed within the lumen of a respective one of the plurality of longitudinally-extending legs or the at least one circumferentially-extending leg. 2. The medical device of claim 1 , wherein the plurality of longitudinally-extending legs extend from a proximal end of the end-effector assembly to a distal end of the end-effector assembly. 3. The medical device of claim 2 , wherein the three-dimensional sphere is configured to transition between a compressed delivery configuration and an expanded deployed configuration. 4. The medical device of claim 1 , wherein the end-effector assembly includes an inflatable member and the plurality of sensing elements are disposed about an exterior surface of the inflatable member. 5. The medical device of claim 1 , wherein the plurality of sensing elements are configured to detect changes in one of a urinary structure and urine within a bladder. 6. The medical device of claim 1 , wherein the plurality of sensing elements are configured to wirelessly transmit sensed data to an external component. 7. The medical device of claim 1 , wherein the plurality of sensing elements includes at least one of a pressure sensor, a flow sensor, a displacement sensor, a vibration sensor, a voltage sensor, a Doppler sensor, a chemical sensor, or a biosensor. 8. The medical device of claim 1 , wherein each of the plurality of longitudinally-extending legs is tubular. 9. A medical device, comprising: an elongate member having a proximal end and a distal end; and an end-effector assembly extending distally from the distal end of the elongate member, the end-effector assembly including a plurality of independently steerable sensing elements for detecting abnormal organ function, wherein the end-effector assembly is configured to transition between a collapsed configuration and an expanded configuration; wherein the end-effector assembly further includes a plurality of longitudinally-extending legs and at least one circumferentially-extending leg which form a three-dimensional sphere, and wherein each of the plurality of longitudinally-extending legs and the at least one circumferentially-extending leg defines a lumen therein, and at least a portion of at least one of the plurality of independently steerable sensing elements is disposed within the lumen of a respective one of the plurality of longitudinally-extending legs or the at least one circumferentially-extending leg. 10. The medical device of claim 9 , wherein the plurality of sensing elements includes one or more of mechanical, chemical, and biological sensors. 11. The medical device of claim 9 , further including: a delivery sheath axially movable relative to the elongate member. 12. The medical device of claim 9 , wherein at least one sensing element is movable relative to a leg to which it is coupled. 13. The medical device of claim 9 , wherein the plurality of sensing elements includes at least one of a pressure sensor, a flow sensor, a displacement sensor, a vibration sensor, a voltage sensor, a Doppler sensor, a chemical sensor, or a biosensor. 14. The medical device of claim 9 , wherein the plurality of sensing elements are configured to detect changes in one of a urinary structure and urine within a bladder. 15. The medical device of claim 9 , wherein the plurality of sensing elements are configured to wirelessly transmit sensed data to an external component. 16. A medical device, comprising: an elongate member having a proximal end and a distal end; and an end-effector assembly extending distally from the distal end of the elongate member, the end-effector assembly including a plurality of sensing elements for detecting abnormal organ function, wherein each of the sensing elements is independently steerable of one another, and wherein the plurality of sensing elements are configured to transmit sensed data to an external component; wherein the end-effector assembly further includes a plurality of longitudinally-extending legs and at least one circumferentially-extending leg which form a three-dimensional sphere, wherein each of the plurality of longitudinally-extending legs and at least one circumferentially-extending leg defines a lumen therein, and at least a portion of at least one of the plurality of independently steerable sensing elements is disposed within the lumen of a respective one of the plurality of longitudinally-extending legs or the at least one circumferentially extending leg. 17. The medical device of claim 16 , wherein the plurality of longitudinally-extending legs extend from a proximal end of the end-effector assembly to a distal end of the end-effector assembly. 18. The medical device of claim 17 , wherein the three-dimensional sphere is configured to transition between a compressed delivery configuration and an expanded deployed configuration. 19. The medical device of claim 16 , wherein each of the plurality of sensing elements is configured to transmit sensed data wirelessly. 20. The medical device of claim 16 , wherein the plurality of sensing elements are configured to detect changes in one of a urinary structure and urine within a bladder.

Assignees

Inventors

Classifications

  • invasive, e.g. introduced into the body by a catheter · CPC title

  • for measuring dimensions inside body cavities, e.g. using catheters (A61B3/1005 takes precedence) · CPC title

  • Monitoring or testing the effects of treatment, e.g. of medication · CPC title

  • involving Doppler signals · CPC title

  • in a matrix array · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9492113B2 cover?
A medical device for monitoring physical, chemical, or biological characteristics of an organ, such as the urinary bladder. The medical device may include an elongate member having a proximal end and a distal end. The device may further include an end-effector assembly extending distally from the distal end of the elongate member. The end-effector assembly may also include a plurality of sensin…
Who is the assignee on this patent?
Nagale Sandra, Cheng Ruth, Boston Scient Scimed Inc
What technology area does this patent fall under?
Primary CPC classification A61B5/205. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).